// App-Quantinova.ai

10569 : Off-label use of bevacizumab in relapsed and refractory pediatric sarcoma patients: The Memorial Sloan Kettering Cancer Center Experience.

Researchers

Presenter

  • Emily Kanaya Slotkin

Principal Investigators

  • Heather D. Magnan

  • Paul A. Meyers

  • Alexander J. Chou

  • Srikanth R. Ambati

  • Leonard H. Wexler

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Desmoplastic small round cell tumour

  • Rhabdomyosarcoma

  • Ewing's sarcoma

  • Sarcoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved